Regional Business Director - Southwest Pacific
PharmaEssentia U.S.A.
About this role
PharmaEssentia is seeking a Regional Business Director to lead sales efforts in a specified region, managing a team to promote biopharmaceutical products for hematology and oncology. The role involves strategic planning, team leadership, cross-functional collaboration, and driving commercial success for cancer treatments.
Skills
About PharmaEssentia U.S.A.
pharmaessentia.comPharmaEssentia is a Taiwan-based global biopharmaceutical company focused on researching, developing, and commercializing best-in-class therapies for blood disorders and other serious diseases. Its portfolio includes Ropeginterferon alfa‑2b (marketed as Besremi) for polycythemia vera and other myeloproliferative neoplasms, and the company conducts clinical trials, medical affairs, and manufacturing activities worldwide. PharmaEssentia provides resources for patients and healthcare professionals and emphasizes innovation in protein engineering and biologics production. It aims to bring effective, scientifically driven treatments to patients through robust R&D and global partnerships.
About PharmaEssentia U.S.A.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for PharmaEssentia U.S.A..
Salary
$225k – $245k
per year
More jobs at PharmaEssentia U.S.A.
Similar Jobs
Regional Business Director (Southwest)
Cgoncologycareers
Regional Business Director (West)
Cgoncologycareers
Regional Business Director (Southeast)
Cgoncologycareers
Associate Director, Regional Sales & Marketing – GCC
BeOne Medicines
Regional Business Director
Taiho Oncology, Inc.
Regional Business Director, Auvelity (Jacksonville, FL)
Axsome Therapeutics